Intio

Intio

Medical Devices, 325 Interlocken Pkwy, Broomfield, Colorado, 80021, United States, 11-50 Employees

intio.us

  • twitter
  • LinkedIn

phone no Phone Number: +13*********

Who is INTIO

INTIO's focus is on all interventional oncologic therapies including surgery, ablation, chemoembolization or radioembolization, and palliation for pain or relief of obstructions. INTIO is...

Read More

map
  • 325 Interlocken Pkwy, Broomfield, Colorado, 80021, United States Headquarters: 325 Interlocken Pkwy, Broomfield, Colorado, 80021, United States
  • 2005 Date Founded: 2005
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from INTIO

Intio Org Chart and Mapping

Employees

Mike Ullrich

Senior Software Engineer | Manager of Software Engineering

Similar Companies to Intio

Inito

  • 51-200 51-200
  • Under 1 Million $ Under 1 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Intio

Answer: Intio's headquarters are located at 325 Interlocken Pkwy, Broomfield, Colorado, 80021, United States

Answer: Intio's phone number is +13*********

Answer: Intio's official website is https://intio.us

Answer: Intio's revenue is $1 Million to $5 Million

Answer: Intio's SIC: 8731

Answer: Intio has 11-50 employees

Answer: Intio is in Medical Devices

Answer: Intio top competitors include: Inito

Answer: Intio contact info: Phone number: +13********* Website: https://intio.us

Answer: INTIO's focus is on all interventional oncologic therapies including surgery, ablation, chemoembolization or radioembolization, and palliation for pain or relief of obstructions. INTIO is committed to developing software tools for planning, image guidance and quantitative image analysis for the interventional oncology market. Whether cancer patients are treated by systemic, local or regional therapies, INTIO has solutions that aid the physician planning, treating and assessing the effectiveness of the particular therapy being used to treat the patient's cancer. The INTIO ClearStart SVM(TM) Segmentation and Volumetric Measurement system received FDA 510(k) clearance in December 2011 for applications in lung, liver, and lymph node lesions.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access